Literature DB >> 27647962

Association between Apolipoprotein ε4 Gene Polymorphism and Risk of Ischemic Stroke: A Meta-Analysis.

Amit Kumar1, Pradeep Kumar1, Manya Prasad1, Shubham Misra1, Awadh Kishor Pandit1, Kamalesh Chakravarty1.   

Abstract

BACKGROUND: Previous studies examining the association of apolipoprotein E (APOE) gene polymorphism with the risk of ischemic stroke (IS) have yielded conflicting results. Therefore, we performed a meta-analysis to investigate the association between APOE ε4 gene polymorphism and risk of IS.
SUMMARY: A literature search for genetic association studies published before May 30, 2015, was conducted in the PubMed, EMBASE and Google Scholar databases. The following search terms were used: (apolipoprotein E) or (APOE) and (ε4) and (polymorphism) or (polymorphisms) and ('ischemic stroke' or 'IS') and ('cerebral infarction' or 'CI') and ('genetic polymorphism' or 'single nucleotide polymorphisms' or 'SNP'). ORs and 95% CIs were used to calculate the strength of association. Begg's funnel plot was used to assess the potential for publication bias. In our meta-analysis, 26 case-control studies involving 6,397 IS cases and 19,053 controls were included. Overall significant association between carrier of ε4 allele and risk of IS was observed (OR 1.43, 95% CI 1.10-1.85, p = 0.007). In the subgroup analysis based on ethnicity, a significant association between Apo ε4 carrier and risk of IS was observed in Asian studies (OR 1.53, 95% CI 1.04-2.25, p = 0.031) whereas borderline significant association between APO ε4 carrier and risk of IS was observed in Caucasian studies (OR 1.36, 95% CI 0.95-1.93, p = 0.093). KEY MESSAGES: Our meta-analysis suggests that APOE ε4 allele is associated with higher risk of IS in Asian population as compared to Caucasian population.

Entities:  

Keywords:  Apolipoprotein-E; Association study; Cerebral infarction; Gene polymorphism; Ischemic stroke; Meta-analysis

Year:  2016        PMID: 27647962      PMCID: PMC5020389          DOI: 10.1159/000443568

Source DB:  PubMed          Journal:  Ann Neurosci        ISSN: 0972-7531


  42 in total

Review 1.  Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology.

Authors:  John Attia; Ammarin Thakkinstian; Catherine D'Este
Journal:  J Clin Epidemiol       Date:  2003-04       Impact factor: 6.437

Review 2.  Apolipoprotein E and the CNS response to injury.

Authors:  D T Laskowitz; K Horsburgh; A D Roses
Journal:  J Cereb Blood Flow Metab       Date:  1998-05       Impact factor: 6.200

3.  Lack of association between apolipoprotein E genoype and ischaemic stroke in a Scottish population.

Authors:  M J MacLeod; R P De Lange; G Breen; D Meiklejohn; H Lemmon; D S Clair
Journal:  Eur J Clin Invest       Date:  2001-07       Impact factor: 4.686

4.  Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults.

Authors:  Alessandro Pezzini; Mario Grassi; Elisabetta Del Zotto; Silvana Archetti; Raffaella Spezi; Veronica Vergani; Deodato Assanelli; Luigi Caimi; Alessandro Padovani
Journal:  Stroke       Date:  2005-02-03       Impact factor: 7.914

5.  Association of genetic variation in apolipoprotein E and low density lipoprotein receptor with ischemic stroke in Northern Han Chinese.

Authors:  Bin Wang; Hongye Zhao; Li Zhou; Xiaoxia Dai; Dayu Wang; Jun Cao; Wenquan Niu
Journal:  J Neurol Sci       Date:  2008-10-11       Impact factor: 3.181

6.  Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland.

Authors:  Stephen P McIlroy; Kevin B Dynan; John T Lawson; Christopher C Patterson; A Peter Passmore
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

7.  Associations of apolipoprotein E exon 4 and lipoprotein lipase S447X polymorphisms with acute ischemic stroke and myocardial infarction.

Authors:  Larry Baum; Ho Keung Ng; Ka Sing Wong; Brian Tomlinson; Timothy Hudson Rainer; Xiangyan Chen; Wing Sze Cheung; Jinling Tang; Wilson Wai San Tam; William Goggins; Cindy See Wai Tong; Daniel Kam Yin Chan; G Neil Thomas; Ping Chook; Kam Sang Woo
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

8.  Meta-analysis of APOE ε2/ε3/ε4 polymorphism and cerebral infarction.

Authors:  Qian-you Wang; Wen-jing Wang; Lei Wu; Liang Liu; Li-zhu Han
Journal:  J Neural Transm (Vienna)       Date:  2013-04-10       Impact factor: 3.575

9.  Apolipoprotein E genotype in patients with cerebrovascular diseases and its effect on the disease outcome.

Authors:  Yusuf Tamam; Nebahat Tasdemir; Recep Toprak; Banu Tamam; Kenan Iltumur
Journal:  Int J Neurosci       Date:  2009       Impact factor: 2.292

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21
View more
  11 in total

1.  The SG13S114 polymorphism of the ALOX5AP gene is associated with ischemic stroke in Europeans: a meta-analysis of 8062 subjects.

Authors:  Zhongjun Chen; Jinyu Zheng; Wenguang Liu; Kun Yang; Kai Li; Baosheng Huang; Ronglan Zhu; Xiaocheng Lu; Lixin Li
Journal:  Neurol Sci       Date:  2017-01-18       Impact factor: 3.307

2.  New evidence from plasma ceramides links apoE polymorphism to greater risk of coronary artery disease in Finnish adults.

Authors:  Juho-Pekka Karjalainen; Nina Mononen; Nina Hutri-Kähönen; Miikael Lehtimäki; Mika Hilvo; Dimple Kauhanen; Markus Juonala; Jorma Viikari; Mika Kähönen; Olli Raitakari; Reijo Laaksonen; Terho Lehtimäki
Journal:  J Lipid Res       Date:  2019-07-03       Impact factor: 5.922

3.  The effect of apolipoprotein E polymorphism on serum metabolome - a population-based 10-year follow-up study.

Authors:  Juho-Pekka Karjalainen; Nina Mononen; Nina Hutri-Kähönen; Miikael Lehtimäki; Markus Juonala; Mika Ala-Korpela; Mika Kähönen; Olli Raitakari; Terho Lehtimäki
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

4.  Association between K469E polymorphism of ICAM-1 gene and susceptibility of ischemic stroke: An updated meta-analysis.

Authors:  Gaurav Nepal; Jayant Kumar Yadav; YuHui Kong
Journal:  Mol Genet Genomic Med       Date:  2019-06-03       Impact factor: 2.183

5.  Association between Lys198Asn polymorphism of endothelin-1 gene and ischemic stroke: A meta-analysis.

Authors:  Gaurav Nepal; Rajeev Ojha; Hari Prasad Dulal; Binod Kumar Yadav
Journal:  Brain Behav       Date:  2019-09-30       Impact factor: 2.708

6.  Glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) gene polymorphism (rs4998386) and Parkinson's disease susceptibility: A meta-analysis.

Authors:  Gaurav Nepal; Jessica Holly Rehrig; Rajeev Ojha
Journal:  Aging Med (Milton)       Date:  2019-07-23

7.  APOE ε4 is associated with younger age at ischemic stroke onset but not with stroke outcome.

Authors:  Cecilia Lagging; Erik Lorentzen; Tara M Stanne; Annie Pedersen; Martin Söderholm; John W Cole; Katarina Jood; Robin Lemmens; Chia-Ling Phuah; Natalia S Rost; Vincent Thijs; Daniel Woo; Jane M Maguire; Arne Lindgren; Christina Jern
Journal:  Neurology       Date:  2019-10-16       Impact factor: 9.910

8.  Association of Apolipoprotein E Polymorphisms and Risks of Ischemic Stroke in Chinese Patients with Type 2 Diabetes Mellitus.

Authors:  Na Wang; Qian Liu; Hui Liu; Xiao Cong; Hui Yang; Yang Yu; Yongtong Cao; Liang Ma
Journal:  J Diabetes Res       Date:  2021-01-03       Impact factor: 4.011

9.  Association of Apolipoprotein E Gene Polymorphism with Lipid Profile and Ischemic Stroke Risk in Type 2 Diabetes Mellitus Patients.

Authors:  Ni Putu Tesi Maratni; Made Ratna Saraswati; Ni Nyoman Ayu Dewi; I Wayan Putu Sutirta Yasa; I Putu Eka Widyadharma; Ida Bagus Kusuma Putra; Ketut Suastika
Journal:  J Nutr Metab       Date:  2021-03-26

10.  Association of apolipoprotein E genotype with outcome in hospitalized ischemic stroke patients.

Authors:  Yajing Zhang; Shuling Liu; Wei Yue; Zhihong Shi; Yalin Guan; Mingzi Li; Yong Ji; Xin Li
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.